BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
90:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
are best followed up by an oncologist or :@0.084848:0.351133:0.481128:0.351133:0.481128:0.335377:0.084848:0.335377:0.013143:0.005715:0.012508:0.007312:0.013123:0.012508:0.007466:0.006523:0.007312:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.012508:0.013181:0.007312:0.011699:0.013123:0.007312:0.013123:0.010314:0.007312:0.013143:0.011738:0.007312:0.012604:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.007295:0.012604:0.005792:0.005330
haematologist for close monitoring and a :@0.084848:0.367392:0.481088:0.367392:0.481088:0.351636:0.084848:0.351636:0.011738:0.013143:0.012508:0.018049:0.013143:0.006523:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.006350:0.006042:0.012604:0.005792:0.006350:0.012450:0.003848:0.012604:0.007466:0.012508:0.006350:0.018049:0.012604:0.011738:0.003848:0.006523:0.012604:0.005792:0.003848:0.011738:0.012950:0.006350:0.013143:0.011738:0.013181:0.006350:0.013143:0.005330
decision for when to initiate therapy.:@0.084848:0.383651:0.425131:0.383651:0.425131:0.367895:0.084848:0.367895:0.013181:0.012508:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.006042:0.012604:0.005792:0.005330:0.015990:0.011738:0.012508:0.011738:0.005330:0.006523:0.012604:0.005330:0.003848:0.011738:0.003848:0.006523:0.003848:0.013143:0.006523:0.012508:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
The  complications of MM frequently :@0.103032:0.399909:0.481105:0.399909:0.481105:0.384153:0.103032:0.384153:0.008197:0.011738:0.012508:0.005330:0.009804:0.012450:0.012604:0.018049:0.013123:0.003848:0.003848:0.012450:0.013154:0.006523:0.003848:0.012604:0.011738:0.007466:0.015144:0.012604:0.006042:0.015144:0.017684:0.017684:0.015144:0.006042:0.005711:0.012508:0.013123:0.011699:0.012508:0.011738:0.006523:0.003848:0.010314:0.005330
seen  that  require  specific  treatment  are :@0.084848:0.416168:0.481098:0.416168:0.481098:0.400412:0.084848:0.400412:0.007466:0.012508:0.012508:0.011738:0.005330:0.004239:0.006523:0.011738:0.013143:0.006523:0.005330:0.004241:0.005713:0.012508:0.013123:0.011699:0.003848:0.005717:0.012508:0.005330:0.004239:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.005330:0.004247:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004235:0.013143:0.005715:0.012508:0.005330
hypercalcaemia,  renal  insufficiency,  in-:@0.084848:0.432426:0.475754:0.432426:0.475754:0.416671:0.084848:0.416671:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330:0.008651:0.005713:0.012508:0.011738:0.013143:0.003848:0.005330:0.008646:0.003848:0.011738:0.007466:0.011699:0.006042:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.012450:0.010314:0.005330:0.005330:0.008640:0.003848:0.011738:0.006388
fection and skeletal lesions. Details on the :@0.084848:0.448685:0.481103:0.448685:0.481103:0.432929:0.084848:0.432929:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.006002:0.013143:0.011738:0.013181:0.006011:0.007466:0.009660:0.012508:0.003848:0.012508:0.006523:0.013143:0.003848:0.006023:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.005330:0.006013:0.014316:0.012508:0.006523:0.013143:0.003848:0.003848:0.007466:0.006023:0.012604:0.011738:0.006004:0.006523:0.011738:0.012508:0.005330
management of these conditions follows. :@0.084848:0.464944:0.481101:0.464944:0.481101:0.449188:0.084848:0.449188:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.006854:0.012604:0.006042:0.006870:0.006523:0.011738:0.012508:0.007466:0.012508:0.006860:0.012450:0.012604:0.011738:0.013181:0.003848:0.006523:0.003848:0.012604:0.011738:0.007466:0.006870:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.007466:0.005330:0.005330
Patients with MM are at an increased :@0.084848:0.481202:0.481105:0.481202:0.481105:0.465446:0.084848:0.465446:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.012642:0.015990:0.003848:0.006523:0.011738:0.012642:0.017684:0.017684:0.012642:0.013143:0.005715:0.012508:0.012642:0.013143:0.006523:0.012642:0.013143:0.011738:0.012642:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330
thrombotic risk and when admitted to hos-:@0.084848:0.497461:0.475769:0.497461:0.475769:0.481705:0.084848:0.481705:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.012604:0.006523:0.003848:0.012450:0.004445:0.005792:0.003848:0.007466:0.009660:0.004445:0.013143:0.011738:0.013181:0.004445:0.015990:0.011738:0.012508:0.011738:0.004445:0.013143:0.013181:0.018049:0.003848:0.006523:0.006523:0.012508:0.013181:0.004445:0.006523:0.012604:0.004445:0.011738:0.012604:0.007466:0.006388
pital, prophylactic anticoagulation is ad-:@0.084848:0.513720:0.475767:0.513720:0.475767:0.497964:0.084848:0.497964:0.013123:0.003848:0.006523:0.013143:0.003848:0.005330:0.008101:0.013123:0.005715:0.012604:0.013123:0.011738:0.010314:0.003848:0.013143:0.012450:0.006523:0.003848:0.012450:0.008091:0.013143:0.011738:0.006523:0.003848:0.012450:0.012604:0.013143:0.012950:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.008101:0.003848:0.007466:0.008101:0.013143:0.013181:0.006388
vised in the absence of contra-indications.:@0.084848:0.529978:0.475756:0.529978:0.475756:0.514222:0.084848:0.514222:0.010660:0.003848:0.007466:0.012508:0.013181:0.004195:0.003848:0.011738:0.004195:0.006523:0.011738:0.012508:0.004185:0.013143:0.013123:0.007466:0.012508:0.011738:0.012450:0.012508:0.004195:0.012604:0.006042:0.004195:0.012450:0.012604:0.011738:0.006523:0.005792:0.013131:0.006388:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
n   :@0.084848:0.559304:0.107657:0.559304:0.107657:0.550864:0.084848:0.550864:0.009762:0.003566:0.005914:0.003566
Hypercalcaemia:@0.104091:0.562423:0.261420:0.562423:0.261420:0.546667:0.104091:0.546667:0.013143:0.010314:0.013123:0.012508:0.005661:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143
The treatment depends on the level of :@0.084848:0.578682:0.481101:0.578682:0.481101:0.562926:0.084848:0.562926:0.008197:0.011738:0.012508:0.010737:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.010737:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.007466:0.010737:0.012604:0.011738:0.010737:0.006523:0.011738:0.012508:0.010737:0.003848:0.012508:0.010660:0.012508:0.003848:0.010737:0.012604:0.006042:0.005330
calcium, and the patient’s symptoms. For :@0.084848:0.594940:0.481107:0.594940:0.481107:0.579184:0.084848:0.579184:0.012450:0.013143:0.003848:0.012450:0.003848:0.011699:0.018049:0.005330:0.006600:0.013143:0.011738:0.013181:0.006600:0.006523:0.011738:0.012508:0.006600:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.006754:0.007466:0.006600:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.007466:0.005330:0.006600:0.009333:0.012604:0.005792:0.005330
mild cases of hypercalcaemia (e.g., calci-:@0.084848:0.611199:0.475742:0.611199:0.475742:0.595443:0.084848:0.595443:0.018049:0.003848:0.003848:0.013181:0.004745:0.012450:0.013143:0.007466:0.012508:0.007466:0.004734:0.012604:0.006042:0.004734:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013154:0.004734:0.007100:0.012508:0.005330:0.012950:0.005330:0.005330:0.004734:0.012450:0.013143:0.003848:0.012450:0.003848:0.006388
um <3mmol/ L) hydration (preferably with :@0.084848:0.627458:0.481092:0.627458:0.481092:0.611702:0.084848:0.611702:0.011699:0.018049:0.006337:0.011661:0.010660:0.018049:0.018049:0.012604:0.003848:0.008409:0.006337:0.008890:0.007100:0.006338:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.006331:0.007100:0.013123:0.005719:0.012508:0.006042:0.012508:0.005792:0.013143:0.013123:0.003848:0.010314:0.006350:0.015990:0.003848:0.006523:0.011738:0.005330
normal saline) and treatment  with corti-:@0.084848:0.643716:0.475765:0.643716:0.475765:0.627960:0.084848:0.627960:0.011738:0.012604:0.006317:0.018049:0.013143:0.003848:0.009717:0.007466:0.013143:0.003848:0.003848:0.011738:0.012508:0.007100:0.009717:0.013143:0.011738:0.013181:0.009717:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004374:0.015990:0.003848:0.006523:0.011738:0.009717:0.012450:0.012604:0.005792:0.006523:0.003848:0.006388
costeroids is recommended. Note  that :@0.084848:0.659975:0.481090:0.659975:0.481090:0.644219:0.084848:0.644219:0.012450:0.012604:0.007466:0.006523:0.012508:0.005707:0.012604:0.003848:0.013181:0.007466:0.013412:0.003848:0.007466:0.013412:0.005713:0.012508:0.012450:0.012604:0.018049:0.018049:0.012508:0.011738:0.013181:0.012508:0.013170:0.005330:0.013412:0.014239:0.012604:0.006523:0.012508:0.005330:0.008066:0.006523:0.011738:0.013143:0.006523:0.005330
steroids may affect the findings on bone-:@0.084848:0.676234:0.475765:0.676234:0.475765:0.660478:0.084848:0.660478:0.007466:0.006523:0.012508:0.005711:0.012604:0.003848:0.013181:0.007466:0.006935:0.018049:0.013143:0.010314:0.006937:0.013143:0.006098:0.006042:0.012508:0.012450:0.006523:0.006925:0.006523:0.011738:0.012508:0.006923:0.004686:0.004686:0.011738:0.013181:0.003848:0.011738:0.012950:0.007466:0.006931:0.012604:0.011738:0.006925:0.013123:0.012604:0.011738:0.012508:0.006388
marrow biopsy and in these patients with :@0.084848:0.692492:0.481094:0.692492:0.481094:0.676736:0.084848:0.676736:0.018049:0.013143:0.005792:0.005711:0.012604:0.015990:0.006966:0.013123:0.003848:0.012604:0.013123:0.007466:0.010314:0.006966:0.013143:0.011738:0.013181:0.006966:0.003848:0.011738:0.006966:0.006523:0.011738:0.012508:0.007466:0.012508:0.006956:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.006966:0.015990:0.003848:0.006523:0.011738:0.005330
mild hypercalcaemia, a bone-marrow ex-:@0.084848:0.708751:0.475742:0.708751:0.475742:0.692995:0.084848:0.692995:0.018049:0.003848:0.003848:0.013181:0.005457:0.011738:0.010314:0.013123:0.012508:0.005653:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005446:0.013143:0.005446:0.013123:0.012604:0.011738:0.012508:0.006388:0.018049:0.013143:0.005792:0.005711:0.012604:0.015990:0.005446:0.012508:0.009236:0.006388
amination is preferably performed before :@0.084848:0.725010:0.481101:0.725010:0.481101:0.709254:0.084848:0.709254:0.013143:0.018049:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.006331:0.003848:0.007466:0.006331:0.013123:0.005715:0.012508:0.006042:0.012508:0.005792:0.013143:0.013123:0.003848:0.010314:0.006331:0.013123:0.012508:0.006708:0.006042:0.012604:0.006319:0.018049:0.012508:0.013181:0.006331:0.013123:0.012508:0.006042:0.012604:0.005709:0.012508:0.005330
steroid therapy.:@0.084848:0.741268:0.230490:0.741268:0.230490:0.725512:0.084848:0.725512:0.007466:0.006523:0.012508:0.005711:0.012604:0.003848:0.013181:0.005330:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
In moderate to severe hypercalcaemia, :@0.103032:0.757527:0.481113:0.757527:0.481113:0.741771:0.103032:0.741771:0.004349:0.011738:0.005157:0.018049:0.012604:0.013181:0.012508:0.005792:0.013143:0.006523:0.012508:0.005143:0.006523:0.012604:0.005157:0.007466:0.012508:0.010660:0.012508:0.005715:0.012508:0.005157:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
treatment includes hydration, corticoster-:@0.084848:0.773786:0.475758:0.773786:0.475758:0.758030:0.084848:0.758030:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007264:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.007466:0.007274:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005321:0.007274:0.012450:0.012604:0.005792:0.006523:0.003848:0.012450:0.012604:0.007466:0.006523:0.012508:0.005778:0.006388
oids as above, and bisphosphonates such :@0.084848:0.790044:0.481061:0.790044:0.481061:0.774288:0.084848:0.774288:0.012604:0.003848:0.013181:0.007466:0.005234:0.013143:0.007466:0.005245:0.013143:0.013123:0.012604:0.010660:0.012508:0.005330:0.005234:0.013143:0.011738:0.013181:0.005234:0.013123:0.003848:0.007466:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.011738:0.013143:0.006523:0.012508:0.007466:0.005234:0.007466:0.011699:0.012450:0.011738:0.005330
as zoledronic acid or pamidronate. Hydra-:@0.084848:0.806303:0.475746:0.806303:0.475746:0.790547:0.084848:0.790547:0.013143:0.007466:0.004349:0.008178:0.012604:0.003848:0.012508:0.013181:0.005707:0.012604:0.011738:0.003848:0.012450:0.004349:0.013143:0.012450:0.003848:0.013181:0.004349:0.012604:0.005792:0.004349:0.013123:0.013143:0.018049:0.003848:0.013181:0.005723:0.012604:0.011738:0.013143:0.006523:0.012508:0.005330:0.004337:0.013143:0.010314:0.013181:0.005792:0.013143:0.006388
tion is critically important as these patients :@0.084848:0.822561:0.481088:0.822561:0.481088:0.806806:0.084848:0.806806:0.006523:0.003848:0.012604:0.011738:0.005201:0.003848:0.007466:0.005215:0.012450:0.005792:0.003848:0.006523:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005215:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005199:0.013143:0.007466:0.005215:0.006523:0.011738:0.012508:0.007466:0.012508:0.005205:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
are typically  very dehydrated. A reason-:@0.084848:0.838820:0.475771:0.838820:0.475771:0.823064:0.084848:0.823064:0.013143:0.005715:0.012508:0.008332:0.006523:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.003017:0.010660:0.012508:0.005792:0.010314:0.008332:0.013181:0.012508:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.012508:0.013181:0.005330:0.008332:0.014239:0.008332:0.005713:0.012508:0.013143:0.007466:0.012604:0.011738:0.006388
able regimen is to give isotonic saline at :@0.084848:0.855079:0.481067:0.855079:0.481067:0.839323:0.084848:0.839323:0.013143:0.013123:0.003848:0.012508:0.008178:0.005713:0.012508:0.012950:0.003848:0.018049:0.012508:0.011738:0.008178:0.003848:0.007466:0.008178:0.006523:0.012604:0.008178:0.012950:0.003848:0.010660:0.012508:0.008178:0.003848:0.007466:0.012604:0.006523:0.012604:0.011738:0.003848:0.012450:0.008178:0.007466:0.013143:0.003848:0.003848:0.011738:0.012508:0.008178:0.013143:0.006523:0.005330
200-300  ml/hour  that  is then  adjusted to :@0.084848:0.871337:0.481105:0.871337:0.481105:0.855581:0.084848:0.855581:0.010660:0.010660:0.010660:0.006388:0.010660:0.010660:0.010660:0.005330:0.004016:0.018049:0.003848:0.008409:0.011738:0.012604:0.011699:0.005792:0.005330:0.003983:0.006523:0.011738:0.013143:0.006523:0.005330:0.003987:0.003848:0.007466:0.009333:0.006523:0.011738:0.012508:0.011738:0.005330:0.003983:0.013143:0.013181:0.003906:0.011699:0.007466:0.006523:0.012508:0.013181:0.009333:0.006523:0.012604:0.005330
maintain the urine output at 100-150  ml/:@0.084848:0.887596:0.475748:0.887596:0.475748:0.871840:0.084848:0.871840:0.018049:0.013143:0.003848:0.011738:0.006523:0.013143:0.003848:0.011738:0.008332:0.006523:0.011738:0.012508:0.008332:0.011699:0.005792:0.003848:0.011738:0.012508:0.008332:0.012604:0.011699:0.006523:0.013123:0.011699:0.006523:0.008332:0.013143:0.006523:0.008332:0.010660:0.010660:0.010660:0.006388:0.010660:0.010660:0.010660:0.005330:0.003031:0.018049:0.003848:0.008409
hour. Saline therapy requires careful moni-:@0.084848:0.903855:0.475758:0.903855:0.475758:0.888099:0.084848:0.888099:0.011738:0.012604:0.011699:0.004370:0.005330:0.005349:0.009583:0.013143:0.003848:0.003848:0.011738:0.012508:0.005349:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005349:0.005713:0.012508:0.013123:0.011699:0.003848:0.005715:0.012508:0.007466:0.005349:0.012450:0.013143:0.005715:0.012508:0.006042:0.011699:0.003848:0.005349:0.018049:0.012604:0.011738:0.003848:0.006388
toring, especially in patients with impaired :@0.084848:0.920113:0.481088:0.920113:0.481088:0.904357:0.084848:0.904357:0.006523:0.012604:0.005792:0.003848:0.011738:0.012950:0.005330:0.005399:0.012508:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.010314:0.005426:0.003848:0.011738:0.005417:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005426:0.015990:0.003848:0.006523:0.011738:0.005415:0.003848:0.018049:0.013123:0.013143:0.003848:0.005725:0.012508:0.013181:0.005330
renal function. If a patient becomes :@0.084848:0.936372:0.481094:0.936372:0.481094:0.920616:0.084848:0.920616:0.005713:0.012508:0.011738:0.013143:0.003848:0.016471:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011726:0.005330:0.016471:0.004349:0.006042:0.016471:0.013143:0.016471:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.016471:0.013123:0.012508:0.012450:0.012604:0.018049:0.012508:0.007466:0.005330
oedematous,  a loop  diuretic may be :@0.524249:0.351259:0.920511:0.351259:0.920511:0.335503:0.524249:0.335503:0.012604:0.012508:0.013181:0.012508:0.018049:0.013143:0.006523:0.012604:0.011699:0.007466:0.005330:0.005330:0.009271:0.013143:0.014624:0.003848:0.012604:0.012604:0.013123:0.005330:0.009283:0.013181:0.003848:0.011699:0.005715:0.012508:0.006523:0.003848:0.012450:0.014624:0.018049:0.013143:0.010314:0.014624:0.013123:0.012508:0.005330
used. The routine use of loop diuretics in :@0.524249:0.367637:0.920488:0.367637:0.920488:0.351881:0.524249:0.351881:0.011699:0.007466:0.012508:0.013181:0.005330:0.008332:0.008197:0.011738:0.012508:0.008332:0.005713:0.012604:0.011699:0.006523:0.003848:0.011738:0.012508:0.008332:0.011699:0.007466:0.012508:0.008332:0.012604:0.006042:0.008332:0.003848:0.012604:0.012604:0.013123:0.008332:0.013181:0.003848:0.011699:0.005717:0.012508:0.006523:0.003848:0.012450:0.007466:0.008332:0.003848:0.011738:0.005330
hypercalcaemia (with  hyperhydration) :@0.524249:0.384015:0.920486:0.384015:0.920486:0.368259:0.524249:0.368259:0.011738:0.010314:0.013123:0.012508:0.005657:0.012450:0.013143:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143:0.019897:0.007100:0.015990:0.003848:0.006523:0.011738:0.005330:0.014557:0.011738:0.010314:0.013123:0.012508:0.006338:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.007100:0.005330
has largely fallen out of favour with avail-:@0.524249:0.400392:0.915158:0.400392:0.915158:0.384636:0.524249:0.384636:0.011738:0.013143:0.007466:0.006639:0.003848:0.013143:0.005811:0.012950:0.012508:0.003848:0.010314:0.006639:0.006042:0.013143:0.003848:0.003848:0.012508:0.011738:0.006639:0.012604:0.011699:0.006523:0.006629:0.012604:0.006042:0.006639:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.006639:0.015990:0.003848:0.006523:0.011738:0.006639:0.013143:0.010660:0.013143:0.003848:0.003858:0.006388
ability of the bisphosphonates.  Zoledron-:@0.524249:0.416770:0.915157:0.416636:0.915157:0.400880:0.524249:0.401014:0.013143:0.013123:0.003848:0.003848:0.003848:0.006523:0.010314:0.005773:0.012604:0.006042:0.005763:0.006523:0.011738:0.012508:0.005757:0.013123:0.003848:0.007466:0.013123:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.011738:0.013143:0.006523:0.012508:0.007466:0.005330:0.012429:0.005763:0.009236:0.012604:0.003848:0.012508:0.013181:0.005711:0.012604:0.011738:-0.037321
20:@0.809141:0.411017:0.821571:0.411017:0.821571:0.401831:0.809141:0.401831:0.006215:0.006215
ic acid is given IV at a dose of 4 mg over :@0.524241:0.433013:0.920500:0.433013:0.920500:0.417257:0.524241:0.417257:0.003848:0.012450:0.006427:0.013143:0.012450:0.003848:0.013181:0.006427:0.003848:0.007466:0.006427:0.012950:0.003848:0.010660:0.012508:0.011738:0.006427:0.004349:0.013508:0.006427:0.013143:0.006523:0.006427:0.013143:0.006427:0.013181:0.012604:0.007466:0.012508:0.006427:0.012604:0.006042:0.006427:0.010660:0.006427:0.018049:0.012950:0.006427:0.012604:0.010660:0.012508:0.005792:0.005330
15 minutes, and pamidronate IV at a dose :@0.524241:0.449391:0.920468:0.449391:0.920468:0.433635:0.524241:0.433635:0.010660:0.010660:0.004907:0.018049:0.003848:0.011738:0.011699:0.006523:0.012508:0.007466:0.005330:0.004907:0.013143:0.011738:0.013181:0.004907:0.013123:0.013143:0.018049:0.003848:0.013181:0.005721:0.012604:0.011738:0.013143:0.006523:0.012508:0.004907:0.004349:0.013508:0.004907:0.013143:0.006523:0.004907:0.013143:0.004907:0.013181:0.012604:0.007466:0.012508:0.005330
of 60-90 mg over 2 hours. The dose and/:@0.524241:0.465769:0.915160:0.465769:0.915160:0.450013:0.524241:0.450013:0.012604:0.006042:0.007585:0.010660:0.010660:0.006388:0.010660:0.010672:0.007591:0.018049:0.012950:0.007587:0.012604:0.010660:0.012508:0.005792:0.007585:0.010660:0.007601:0.011738:0.012604:0.011699:0.005792:0.007466:0.005330:0.007578:0.008197:0.011738:0.012508:0.007591:0.013181:0.012604:0.007466:0.012508:0.007589:0.013143:0.011738:0.013181:0.008409
or duration of administration of zoledronic :@0.524241:0.482146:0.920483:0.482146:0.920483:0.466390:0.524241:0.466390:0.012604:0.005792:0.005713:0.013181:0.011699:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005715:0.012604:0.006042:0.005717:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005721:0.012604:0.006042:0.005719:0.008178:0.012604:0.003848:0.012508:0.013181:0.005707:0.012604:0.011738:0.003848:0.012450:0.005330
acid needs to be adjusted for renal failure, :@0.524241:0.498524:0.920466:0.498524:0.920466:0.482768:0.524241:0.482768:0.013143:0.012450:0.003848:0.013181:0.004426:0.011738:0.012508:0.012508:0.013181:0.007466:0.004426:0.006523:0.012604:0.004426:0.013123:0.012508:0.004426:0.013143:0.013181:0.003906:0.011699:0.007466:0.006523:0.012508:0.013181:0.004426:0.006042:0.012604:0.005792:0.004426:0.005713:0.012508:0.011738:0.013143:0.003848:0.004426:0.006042:0.013143:0.003848:0.003848:0.011699:0.005721:0.012508:0.005330:0.005330
and in patients who present with acute re-:@0.524241:0.514902:0.915147:0.514902:0.915147:0.499146:0.524241:0.499146:0.013143:0.011738:0.013181:0.004780:0.003848:0.011738:0.004782:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004780:0.015990:0.011738:0.012604:0.004774:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.004774:0.015990:0.003848:0.006523:0.011738:0.004778:0.013143:0.012450:0.011699:0.006523:0.012508:0.004776:0.005711:0.012508:0.006388
nal failure, pamidronate is preferred.:@0.524241:0.531279:0.863722:0.531279:0.863722:0.515524:0.524241:0.515524:0.011738:0.013143:0.003848:0.005330:0.006042:0.013143:0.003848:0.003848:0.011699:0.005721:0.012508:0.005330:0.005330:0.013123:0.013143:0.018049:0.003848:0.013181:0.005713:0.012604:0.011738:0.013143:0.006523:0.012508:0.005330:0.003848:0.007466:0.005330:0.013123:0.005707:0.012508:0.006042:0.012508:0.005792:0.005705:0.012508:0.013181:0.005330
n   :@0.524242:0.560896:0.547050:0.560896:0.547050:0.552456:0.524242:0.552456:0.009762:0.003566:0.005914:0.003566
Renal insufficiency:@0.543484:0.564015:0.715203:0.564015:0.715203:0.548260:0.543484:0.548260:0.011680:0.012508:0.011738:0.013143:0.003848:0.005330:0.003848:0.011738:0.007466:0.011699:0.006042:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.012450:0.010314
The  treatment  of  renal  insufficiency  de-:@0.524242:0.580393:0.915151:0.580393:0.915151:0.564637:0.524242:0.564637:0.008197:0.011738:0.012508:0.005330:0.005486:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005484:0.012604:0.006042:0.005330:0.005488:0.005713:0.012508:0.011738:0.013143:0.003848:0.005330:0.005496:0.003848:0.011738:0.007466:0.011699:0.006042:0.004686:0.004686:0.012450:0.003848:0.012508:0.011738:0.012450:0.010314:0.005330:0.005494:0.013181:0.012508:0.006388
pends on the underlying cause, with cor-:@0.524242:0.596771:0.915151:0.596771:0.915151:0.581015:0.524242:0.581015:0.013123:0.012508:0.011738:0.013181:0.007466:0.007043:0.012604:0.011738:0.007043:0.006523:0.011738:0.012508:0.007043:0.011699:0.011738:0.013181:0.012508:0.005792:0.003848:0.010314:0.003848:0.011738:0.012950:0.007043:0.012450:0.013143:0.011699:0.007466:0.012508:0.005330:0.007043:0.015990:0.003848:0.006523:0.011738:0.007043:0.012450:0.012604:0.005773:0.006388
rection of hydration status and electrolytes :@0.524242:0.613149:0.920476:0.613149:0.920476:0.597393:0.524242:0.597393:0.005713:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.004060:0.012604:0.006042:0.004060:0.011738:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.004060:0.007466:0.006523:0.013143:0.006523:0.011699:0.007466:0.004060:0.013143:0.011738:0.013181:0.004060:0.012508:0.003848:0.012508:0.012450:0.006523:0.005711:0.012604:0.003848:0.010314:0.006523:0.012508:0.007466:0.005330
and avoidance of nephrotoxins (NSAIDs). :@0.524242:0.629526:0.920491:0.629526:0.920491:0.613770:0.524242:0.613770:0.013143:0.011738:0.013181:0.007100:0.013143:0.010660:0.012604:0.003848:0.013181:0.013143:0.011738:0.012450:0.012508:0.007100:0.012604:0.006042:0.007091:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.006523:0.012604:0.009225:0.003848:0.011738:0.007466:0.007100:0.007100:0.014239:0.009583:0.014239:0.004349:0.014316:0.007466:0.007100:0.005330:0.005330
Hydration  should be  carefully  monitored :@0.524242:0.645904:0.920491:0.645904:0.920491:0.630148:0.524242:0.630148:0.013143:0.010314:0.013181:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004201:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.009544:0.013123:0.012508:0.005330:0.004203:0.012450:0.013143:0.005715:0.012508:0.006042:0.011699:0.003848:0.003848:0.010314:0.005330:0.004204:0.018049:0.012604:0.011738:0.003848:0.006523:0.012604:0.005702:0.012508:0.013181:0.005330
and matched  to  output  when a patient :@0.524242:0.662282:0.920501:0.662282:0.920501:0.646526:0.524242:0.646526:0.013143:0.011738:0.013181:0.008582:0.018049:0.013143:0.006523:0.012450:0.011738:0.012508:0.013181:0.005330:0.003240:0.006523:0.012604:0.005330:0.003240:0.012604:0.011699:0.006523:0.013123:0.011699:0.006523:0.005330:0.003237:0.015990:0.011738:0.012508:0.011738:0.008582:0.013143:0.008582:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330
is fluid-replete. In the presence of indica-:@0.524242:0.678659:0.915145:0.678659:0.915145:0.662904:0.524242:0.662904:0.003848:0.007466:0.007505:0.004666:0.004666:0.011699:0.003848:0.013181:0.006388:0.005713:0.012508:0.013123:0.003848:0.012508:0.006523:0.012508:0.005330:0.007491:0.004349:0.011738:0.007495:0.006523:0.011738:0.012508:0.007489:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.007495:0.012604:0.006042:0.007491:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006388
tions for referral, dialysis patients should be :@0.524242:0.695037:0.920478:0.695037:0.920478:0.679281:0.524242:0.679281:0.006523:0.003848:0.012604:0.011738:0.007466:0.004907:0.006042:0.012604:0.005792:0.004907:0.005713:0.012508:0.006042:0.012508:0.005792:0.005792:0.013133:0.003848:0.005330:0.004907:0.013181:0.003848:0.013143:0.003848:0.010314:0.007466:0.003848:0.007466:0.004934:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004907:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.004907:0.013123:0.012508:0.005330
referred promptly. Acute renal failure due :@0.524242:0.711124:0.920493:0.711124:0.920493:0.695368:0.524242:0.695368:0.005713:0.012508:0.006042:0.012508:0.005792:0.005703:0.012508:0.013181:0.005954:0.013123:0.005715:0.012604:0.018049:0.013123:0.006523:0.003848:0.010314:0.005330:0.005965:0.014239:0.012450:0.011699:0.006523:0.012508:0.005942:0.005713:0.012508:0.011738:0.013143:0.003848:0.005956:0.006042:0.013143:0.003848:0.003848:0.011699:0.005721:0.012508:0.005954:0.013181:0.011699:0.012508:0.005330
to  light-chain cast nephropathy is best :@0.524242:0.727210:0.920483:0.727210:0.920483:0.711455:0.524242:0.711455:0.006523:0.012604:0.005330:0.006821:0.003848:0.003848:0.012950:0.011738:0.006523:0.006388:0.012450:0.011738:0.013143:0.003848:0.011738:0.012161:0.012450:0.013143:0.007466:0.006523:0.012161:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314:0.012161:0.003848:0.007466:0.012161:0.013123:0.012508:0.007466:0.006523:0.005330
treated by treatment of the myeloma with :@0.524242:0.743297:0.920493:0.743297:0.920493:0.727541:0.524242:0.727541:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.004695:0.013123:0.010314:0.004695:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.004680:0.012604:0.006042:0.004686:0.006523:0.011738:0.012508:0.004684:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.004695:0.015990:0.003848:0.006523:0.011738:0.005330
a dexamethasone-containing regimen.:@0.524242:0.759384:0.891980:0.759384:0.891980:0.743628:0.524242:0.743628:0.013143:0.005330:0.013181:0.012508:0.009236:0.013143:0.018049:0.012508:0.006523:0.011738:0.013143:0.007466:0.012604:0.011738:0.012508:0.006388:0.012450:0.012604:0.011738:0.006523:0.013143:0.003848:0.011738:0.003848:0.011738:0.012950:0.005330:0.005692:0.012508:0.012950:0.003848:0.018049:0.012508:0.011738:0.005330
n   :@0.524242:0.788390:0.547050:0.788390:0.547050:0.779950:0.524242:0.779950:0.009762:0.003566:0.005914:0.003566
Skeletal lesions:@0.543484:0.791510:0.679913:0.791510:0.679913:0.775754:0.543484:0.775754:0.009583:0.009660:0.012508:0.003848:0.012508:0.006523:0.013143:0.003848:0.005330:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466
Skeletal lesions can result in bone  pain, :@0.524242:0.807596:0.920487:0.807596:0.920487:0.791840:0.524242:0.791840:0.009583:0.009660:0.012508:0.003848:0.012508:0.006523:0.013143:0.003848:0.010333:0.003848:0.012508:0.007466:0.003848:0.012604:0.011738:0.007466:0.010333:0.012450:0.013143:0.011738:0.010333:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.010333:0.003848:0.011738:0.010333:0.013123:0.012604:0.011738:0.012508:0.005330:0.004991:0.013123:0.013143:0.003848:0.011738:0.005330:0.005330
pathological  fractures and  spinal cord :@0.524242:0.823683:0.920485:0.823683:0.920485:0.807927:0.524242:0.807927:0.013123:0.013143:0.006523:0.011738:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.005330:0.008322:0.006042:0.005792:0.013143:0.012450:0.006523:0.011699:0.005705:0.012508:0.007466:0.013662:0.013143:0.011738:0.013181:0.005330:0.008322:0.007466:0.013123:0.003848:0.011738:0.013143:0.003848:0.013662:0.012450:0.012604:0.005671:0.013181:0.005330
compression,  all of  which  are  best  man-:@0.524242:0.839770:0.915157:0.839770:0.915157:0.824014:0.524242:0.824014:0.012450:0.012604:0.018049:0.013123:0.005711:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.003412:0.013143:0.003848:0.003848:0.008755:0.012604:0.006042:0.005330:0.003408:0.015990:0.011738:0.003848:0.012450:0.011738:0.005330:0.003412:0.013143:0.005715:0.012508:0.005330:0.003414:0.013123:0.012508:0.007466:0.006523:0.005330:0.003414:0.018049:0.013143:0.011738:0.006388
aged by a specialist-led  multidisciplinary :@0.524242:0.855856:0.920462:0.855856:0.920462:0.840100:0.524242:0.840100:0.013143:0.012950:0.012508:0.013181:0.008948:0.013123:0.010314:0.008948:0.013143:0.008948:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.006523:0.006388:0.003848:0.012508:0.013181:0.005330:0.003637:0.018049:0.011699:0.003848:0.006523:0.003848:0.013181:0.003848:0.007466:0.012450:0.003848:0.013123:0.003848:0.003848:0.011738:0.013143:0.005792:0.010314:0.005330
team. Patients with myeloma should be :@0.524242:0.871943:0.920501:0.871943:0.920501:0.856187:0.524242:0.856187:0.006523:0.012508:0.013143:0.018049:0.005330:0.009891:0.011392:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.009891:0.015990:0.003848:0.006523:0.011738:0.009891:0.018049:0.010314:0.012508:0.003848:0.012604:0.018049:0.013143:0.009891:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.009891:0.013123:0.012508:0.005330
encouraged to remain as active as pos-:@0.524242:0.888030:0.915117:0.888030:0.915117:0.872274:0.524242:0.872274:0.012508:0.011738:0.012450:0.012604:0.011699:0.005792:0.013143:0.012950:0.012508:0.013181:0.008030:0.006523:0.012604:0.008043:0.005713:0.012508:0.018049:0.013143:0.003848:0.011738:0.008043:0.013143:0.007466:0.008043:0.013143:0.012450:0.006523:0.003848:0.010660:0.012508:0.008043:0.013143:0.007466:0.008043:0.013123:0.012604:0.007466:0.006388
sible in order  to  maintain bone  density :@0.524242:0.904116:0.920483:0.904116:0.920483:0.888360:0.524242:0.888360:0.007466:0.003848:0.013123:0.003848:0.012508:0.011353:0.003848:0.011738:0.011353:0.012604:0.005671:0.013181:0.012508:0.005792:0.005330:0.006009:0.006523:0.012604:0.005330:0.006006:0.018049:0.013143:0.003848:0.011738:0.006523:0.013143:0.003848:0.011738:0.011353:0.013123:0.012604:0.011738:0.012508:0.005330:0.006004:0.013181:0.012508:0.011738:0.007466:0.003848:0.006523:0.010314:0.005330
and take vitamin D supplementation  as :@0.524242:0.920203:0.920468:0.920203:0.920468:0.904447:0.524242:0.904447:0.013143:0.011738:0.013181:0.009968:0.006523:0.013143:0.009660:0.012508:0.009968:0.010660:0.003848:0.006523:0.013143:0.018049:0.003848:0.011738:0.009968:0.014316:0.009968:0.007466:0.011699:0.013123:0.013123:0.003848:0.012508:0.018049:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004624:0.013143:0.007466:0.005330
preventive measures. Bisphosphonate :@0.524242:0.936290:0.920495:0.936290:0.920495:0.920534:0.524242:0.920534:0.013123:0.005715:0.012508:0.010660:0.012508:0.011738:0.006523:0.003848:0.010660:0.012508:0.024284:0.018049:0.012508:0.013143:0.007466:0.011699:0.005715:0.012508:0.007466:0.005330:0.024284:0.011045:0.003848:0.007466:0.013137:0.011738:0.012604:0.007466:0.013123:0.011738:0.012604:0.011738:0.013143:0.006523:0.012508:0.005330
Table 2. The international staging system (R-ISS) for multiple myeloma:@0.084841:0.096211:0.714261:0.096211:0.714261:0.080177:0.084841:0.080177:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.007889:0.011353:0.012123:0.005195:0.004426:0.011353:0.005580:0.012123:0.005965:0.011353:0.012508:0.005580:0.004426:0.012123:0.011353:0.012508:0.004426:0.005195:0.008274:0.005580:0.012508:0.012508:0.004426:0.011353:0.012508:0.005195:0.008274:0.010968:0.008274:0.005580:0.012123:0.017895:0.005195:0.007120:0.010968:0.007889:0.005195:0.009814:0.009814:0.007120:0.005195:0.005195:0.012123:0.005965:0.005195:0.017895:0.011353:0.004426:0.005580:0.004426:0.012508:0.004426:0.012123:0.005195:0.017895:0.010968:0.012123:0.004426:0.012123:0.017895:0.012700
Stage:@0.094474:0.126918:0.147198:0.126918:0.147198:0.110884:0.094474:0.110884:0.009814:0.005580:0.012508:0.012508:0.012315
Criteria:@0.176100:0.126918:0.242102:0.126918:0.242102:0.110884:0.176100:0.110884:0.014817:0.005965:0.004426:0.005580:0.012123:0.005965:0.004426:0.012700
5 year overall :@0.730301:0.126918:0.860568:0.126918:0.860568:0.110884:0.730301:0.110884:0.010583:0.005195:0.010968:0.012123:0.012508:0.005965:0.005195:0.012123:0.010583:0.012123:0.005965:0.012508:0.004426:0.004614:0.005388
survival (%):@0.730301:0.143084:0.834402:0.143084:0.834402:0.127050:0.730301:0.127050:0.008274:0.011353:0.005965:0.010583:0.004426:0.010583:0.012508:0.004426:0.005195:0.007120:0.016356:0.007312
I:@0.094474:0.165507:0.098823:0.165507:0.098823:0.149752:0.094474:0.149752:0.004349
Beta-2-microglobulin <3.5 mg/L and albumin ≥3.5 g/dL:@0.176100:0.165507:0.681837:0.165507:0.681837:0.149752:0.176100:0.149752:0.011045:0.012508:0.006523:0.013143:0.006388:0.010660:0.006388:0.018049:0.003848:0.012450:0.005723:0.012604:0.012950:0.003848:0.012604:0.013123:0.011699:0.003848:0.003848:0.011738:0.005330:0.011661:0.010660:0.005330:0.010660:0.005330:0.018049:0.012950:0.008409:0.008890:0.005330:0.013143:0.011738:0.013181:0.005330:0.013143:0.003848:0.013123:0.011699:0.018049:0.003848:0.011738:0.005330:0.010564:0.010660:0.005330:0.010660:0.005330:0.012950:0.008409:0.013181:0.008890
82:@0.730301:0.165507:0.751621:0.165507:0.751621:0.149752:0.730301:0.149752:0.010660:0.010660
II:@0.094474:0.189357:0.104138:0.189357:0.104138:0.171850:0.094474:0.171850:0.004832:0.004832
Not R-ISS I or III:@0.176096:0.187931:0.308157:0.187931:0.308157:0.172175:0.176096:0.172175:0.014239:0.012604:0.006523:0.005330:0.011680:0.006388:0.004349:0.009583:0.009583:0.005330:0.004349:0.005330:0.012604:0.005792:0.005330:0.004349:0.004349:0.004349
62:@0.730297:0.187931:0.751617:0.187931:0.751617:0.172175:0.730297:0.172175:0.010660:0.010660
III:@0.094474:0.212881:0.108970:0.212881:0.108970:0.195374:0.094474:0.195374:0.004832:0.004832:0.004832
Beta-2-microglobulin ≥5.5 mg/L and either high LDH or :@0.176096:0.211455:0.683238:0.211455:0.683238:0.195699:0.176096:0.195699:0.011045:0.012508:0.006523:0.013143:0.006388:0.010660:0.006388:0.018049:0.003848:0.012450:0.005723:0.012604:0.012950:0.003848:0.012604:0.013123:0.011699:0.003848:0.003848:0.011738:0.005330:0.010564:0.010660:0.005330:0.010660:0.005330:0.018049:0.012950:0.008409:0.008890:0.005330:0.013143:0.011738:0.013181:0.005330:0.012508:0.003848:0.006523:0.011738:0.012508:0.005792:0.005330:0.011738:0.003848:0.012950:0.011738:0.005330:0.008890:0.014316:0.013143:0.005330:0.012604:0.005792:0.005330
high-risk chromosomal abnormalities by I-FISH (defined as :@0.176096:0.227621:0.712030:0.227621:0.712030:0.211865:0.176096:0.211865:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330:0.012450:0.011738:0.005705:0.012604:0.018049:0.012604:0.007466:0.012604:0.018049:0.013143:0.003848:0.005330:0.013143:0.013123:0.011738:0.012604:0.006315:0.018049:0.013143:0.003848:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.013123:0.010314:0.005330:0.004349:0.006388:0.009333:0.004349:0.009583:0.013143:0.005330:0.007100:0.013181:0.012508:0.004686:0.004686:0.011738:0.012508:0.013181:0.005330:0.013143:0.007466:0.005330
presence of del (17p) and/or translocation t(4;14) and/or :@0.176096:0.243787:0.712767:0.243787:0.712767:0.228031:0.176096:0.228031:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.012450:0.012508:0.005330:0.012604:0.006042:0.005330:0.013181:0.012508:0.003848:0.005330:0.007100:0.010660:0.010660:0.013123:0.007100:0.005330:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.012604:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.006523:0.007100:0.010660:0.005330:0.010660:0.010660:0.007100:0.005330:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.005330
translocation t(14;16)):@0.176096:0.259953:0.378642:0.259953:0.378642:0.244197:0.176096:0.244197:0.006523:0.005792:0.013143:0.011738:0.007466:0.003848:0.012604:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.006523:0.007100:0.010660:0.010660:0.005330:0.010660:0.010660:0.007100:0.007100
40:@0.730302:0.212881:0.753992:0.212881:0.753992:0.195374:0.730302:0.195374:0.011845:0.011845
I-FISH = interphase fluorescence :@0.084848:0.280367:0.351043:0.280367:0.351043:0.266362:0.084848:0.266362:0.003866:0.005679:0.008296:0.003866:0.008518:0.011682:0.004738:0.010365:0.004738:0.003421:0.010434:0.005798:0.011118:0.005148:0.011665:0.010434:0.011682:0.006636:0.011118:0.004738:0.004148:0.004148:0.010399:0.011203:0.005063:0.011118:0.006636:0.011067:0.011118:0.010434:0.011067:0.011118:0.004738
in situ:@0.351043:0.280367:0.395891:0.280367:0.395891:0.266362:0.351043:0.266362:0.003421:0.010434:0.004738:0.006636:0.003421:0.005798:0.010399
 hybridisation; LDH = lactate dehydrogenase:@0.395891:0.280367:0.764635:0.280367:0.764635:0.266362:0.395891:0.266362:0.004738:0.010434:0.009168:0.011665:0.005148:0.003421:0.011716:0.003421:0.006636:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738:0.007902:0.012726:0.011682:0.004738:0.010365:0.004738:0.003421:0.011682:0.011067:0.005798:0.011682:0.005798:0.011118:0.004738:0.011716:0.011118:0.010434:0.009168:0.011716:0.005071:0.011203:0.011511:0.011118:0.010434:0.011682:0.006636:0.011118
Source: Adapted from Palumbo A, Avet-Loiseau H, Oliva S,:@0.084848:0.301606:0.509907:0.301606:0.509907:0.289352:0.084848:0.289352:0.007453:0.009803:0.009100:0.004505:0.009683:0.009728:0.004146:0.004146:0.011075:0.010252:0.010222:0.010207:0.005074:0.009728:0.010252:0.004146:0.004699:0.004505:0.009803:0.014038:0.004146:0.008860:0.010222:0.002993:0.009100:0.014038:0.010207:0.009803:0.004146:0.011075:0.004146:0.004146:0.011075:0.008291:0.009728:0.005074:0.004969:0.006914:0.009803:0.002993:0.005807:0.009728:0.010222:0.009100:0.004146:0.010222:0.004146:0.004146:0.013006:0.002993:0.002993:0.008291:0.010222:0.004146:0.007453:0.004146
 et al.:@0.509862:0.301606:0.550316:0.301606:0.550316:0.289352:0.509862:0.289352:0.004146:0.009728:0.005074:0.004146:0.010222:0.002993:0.004146
 Revised international staging system for multiple :@0.550316:0.301606:0.904194:0.301606:0.904194:0.289352:0.550316:0.289352:0.004146:0.009085:0.009728:0.008291:0.002993:0.005807:0.009728:0.010252:0.004146:0.002993:0.009129:0.005074:0.009728:0.004505:0.009129:0.010222:0.005074:0.002993:0.009803:0.009129:0.010222:0.002993:0.004146:0.005807:0.005074:0.010222:0.010072:0.002993:0.009129:0.010072:0.004146:0.005807:0.008022:0.005807:0.005074:0.009728:0.014038:0.004146:0.004699:0.009803:0.004505:0.004146:0.014038:0.009100:0.002993:0.005074:0.002993:0.010207:0.002993:0.009728:0.004146
myeloma: a report from International Myeloma Working Group. :@0.084848:0.314838:0.547233:0.314838:0.547233:0.302584:0.084848:0.302584:0.014038:0.008022:0.009728:0.002993:0.009803:0.014038:0.010222:0.004146:0.004146:0.010222:0.004146:0.004505:0.009728:0.010207:0.009803:0.004505:0.005074:0.004146:0.004699:0.004505:0.009803:0.014038:0.004146:0.003382:0.009129:0.005074:0.009728:0.004505:0.009129:0.010222:0.005074:0.002993:0.009803:0.009129:0.010222:0.002993:0.004146:0.013754:0.008022:0.009728:0.002993:0.009803:0.014038:0.010222:0.004146:0.014368:0.009803:0.004505:0.007513:0.002993:0.009129:0.010072:0.004146:0.013051:0.004505:0.009803:0.009100:0.010207:0.004146:0.004146
J Clin Oncol. :@0.547173:0.314838:0.642867:0.314838:0.642867:0.302584:0.547173:0.302584:0.007214:0.004146:0.012168:0.002993:0.002993:0.009129:0.004146:0.013006:0.009129:0.009683:0.009803:0.002993:0.004146:0.004146
33:2863-2869.:@0.642867:0.314838:0.739041:0.314838:0.739041:0.302584:0.642867:0.302584:0.008291:0.008291:0.004146:0.008291:0.008291:0.008291:0.008291:0.004969:0.008291:0.008291:0.008291:0.008291:0.004146